AboutSign In

ATTAIN-1 trial

Event

Phase 3 clinical trial of orforglipron for obesity in 3,127 adults without diabetes

1 story

01
health1d ago

FDA Approves Eli Lilly's Oral Weight-Loss Drug, Entering Market Against Novo Nordisk

9 min read